n-methyl-3,4-methylenedioxyamphetamine has been researched along with Autism Spectrum Disorder in 2 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Autism Spectrum Disorder: Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaliha, D | 1 |
| Mamo, JC | 1 |
| Albrecht, M | 1 |
| Lam, V | 1 |
| Takechi, R | 1 |
| Vaccarezza, M | 1 |
| Francis, SM | 1 |
| Kirkpatrick, MG | 1 |
| de Wit, H | 1 |
| Jacob, S | 1 |
1 review available for n-methyl-3,4-methylenedioxyamphetamine and Autism Spectrum Disorder
| Article | Year |
|---|---|
A Systematic Review of the MDMA Model to Address Social Impairment in Autism.
Topics: Animals; Autism Spectrum Disorder; Autistic Disorder; Disease Models, Animal; Humans; N-Methyl-3,4-m | 2021 |
1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Autism Spectrum Disorder
| Article | Year |
|---|---|
Urinary and plasma oxytocin changes in response to MDMA or intranasal oxytocin administration.
Topics: Administration, Intranasal; Adolescent; Adult; Autism Spectrum Disorder; Double-Blind Method; Female | 2016 |